Aroa Biosurgery Limited
AROAF
$0.35
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.16% | 17.41% | 14.71% | 10.69% | 6.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.16% | 17.41% | 14.71% | 10.69% | 6.53% |
| Cost of Revenue | 16.10% | 7.77% | -1.25% | -0.72% | -0.22% |
| Gross Profit | 19.68% | 19.12% | 17.64% | 12.80% | 7.78% |
| SG&A Expenses | 5.07% | 13.09% | 21.14% | 23.96% | 27.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 36.53% | 35.45% | 34.74% | 21.26% | 6.09% |
| Total Operating Expenses | 6.97% | 11.80% | 16.18% | 16.66% | 17.25% |
| Operating Income | 71.84% | 29.77% | -28.99% | -88.43% | -235.99% |
| Income Before Tax | 69.09% | 44.42% | 13.66% | -100.14% | -2,913.02% |
| Income Tax Expenses | 174.76% | 301.05% | 769.75% | 899.49% | 1,279.78% |
| Earnings from Continuing Operations | 64.48% | 39.86% | 8.82% | -105.99% | -2,846.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 64.48% | 39.86% | 8.82% | -105.99% | -2,846.93% |
| EBIT | 71.84% | 29.77% | -28.99% | -88.43% | -235.99% |
| EBITDA | 102.14% | 45.59% | -50.97% | -208.71% | -9,320.88% |
| EPS Basic | 65.08% | 40.83% | 9.46% | -106.41% | -3,050.00% |
| Normalized Basic EPS | 68.97% | 44.23% | 14.13% | -97.96% | -2,800.00% |
| EPS Diluted | 65.08% | 40.83% | 9.46% | -101.25% | -1,790.00% |
| Normalized Diluted EPS | 68.97% | 44.23% | 14.13% | -97.96% | -2,800.00% |
| Average Basic Shares Outstanding | 0.31% | 0.13% | 0.39% | 0.34% | 0.30% |
| Average Diluted Shares Outstanding | 0.31% | 0.13% | 0.39% | -0.85% | -2.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |